Market Cap 101.20M
Revenue (ttm) 128.94M
Net Income (ttm) -85.40M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -66.23%
Debt to Equity Ratio 0.00
Volume 44,100
Avg Vol 51,368
Day's Range N/A - N/A
Shares Out 7.02M
Stochastic %K 56%
Beta 0.25
Analysts Sell
Price Target $13.33

Company Profile

Atara Biotherapeutics, Inc. engages in the development of transformative therapies for patients with cancer and autoimmune disease in the United States and the United Kingdom. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) with post-transplant lymphoproliferative disease, as well as other EBV-driven diseases. The company has research collaboration agreements with Memorial Sloan Ket...

Industry: Biotechnology
Sector: Healthcare
Phone: 805 623 4211
Address:
1280 Rancho Conejo Blvd, Thousand Oaks, United States
ninergizer
ninergizer Oct. 3 at 7:14 PM
$ATRA Great entry here. Starting a new position until PDUFA, still low next 3 months run up. Do your DD always. PDUFA: Jan 10, 2026 Tab-cel® (Atara) — Allogeneic T-cell therapy for EBV+ PTLD FDA Likelihood: High (Priority Review, CRL was CMC/inspection). Market Impact: Small population, but ultra-high unmet need. EBV+ PTLD is rare, but mortality is >80% untreated. Orphan pricing likely (>$200K/course). Potential: could bring $200–300M annually plus pave path for allogeneic T-cell therapies.
0 · Reply
takingstock73
takingstock73 Sep. 30 at 9:27 PM
$ATRA do I hear 15 ?
0 · Reply
Doozio
Doozio Sep. 27 at 2:58 PM
$ATRA 🧠 is on the outside with those weekly closes 🐒🍌🧠⏰♾️
0 · Reply
shoagh12
shoagh12 Sep. 25 at 11:56 AM
0 · Reply
hassle
hassle Sep. 24 at 8:04 PM
$ATRA No news, but up and up. Must be good revenue for Q3 than expected.
1 · Reply
takingstock73
takingstock73 Sep. 24 at 4:39 PM
$ATRA let's go
0 · Reply
shoagh12
shoagh12 Sep. 24 at 3:16 PM
0 · Reply
JazzyJ03
JazzyJ03 Sep. 24 at 3:14 PM
0 · Reply
Smurfologist
Smurfologist Sep. 24 at 2:47 PM
$ATRA has beat the last 3 reporting quarters STRAIGHT; let's see if they will beat in the 3rd quarter.......LET'S GO, DAMN IT!!! 🙏🏾💪🏾🐃💣💥🚀
0 · Reply
Smurfologist
Smurfologist Sep. 24 at 2:43 PM
$ATRA is lookin' good rat now......CONGRATS TO THE LONGS and thanks for slappin' them SHORTS in dey mouf HARD!!! DO DAT $HIT, $ATRA!!! 🙏🏾💪🏾🐃💣💥🚀
0 · Reply
Latest News on ATRA
Atara Biotherapeutics Announces Pricing of $16 Million Offering

May 15, 2025, 8:30 AM EDT - 5 months ago

Atara Biotherapeutics Announces Pricing of $16 Million Offering


US FDA declines to approve Atara Biotherapeutics' cancer therapy

Jan 16, 2025, 8:41 AM EST - 9 months ago

US FDA declines to approve Atara Biotherapeutics' cancer therapy


ninergizer
ninergizer Oct. 3 at 7:14 PM
$ATRA Great entry here. Starting a new position until PDUFA, still low next 3 months run up. Do your DD always. PDUFA: Jan 10, 2026 Tab-cel® (Atara) — Allogeneic T-cell therapy for EBV+ PTLD FDA Likelihood: High (Priority Review, CRL was CMC/inspection). Market Impact: Small population, but ultra-high unmet need. EBV+ PTLD is rare, but mortality is >80% untreated. Orphan pricing likely (>$200K/course). Potential: could bring $200–300M annually plus pave path for allogeneic T-cell therapies.
0 · Reply
takingstock73
takingstock73 Sep. 30 at 9:27 PM
$ATRA do I hear 15 ?
0 · Reply
Doozio
Doozio Sep. 27 at 2:58 PM
$ATRA 🧠 is on the outside with those weekly closes 🐒🍌🧠⏰♾️
0 · Reply
shoagh12
shoagh12 Sep. 25 at 11:56 AM
0 · Reply
hassle
hassle Sep. 24 at 8:04 PM
$ATRA No news, but up and up. Must be good revenue for Q3 than expected.
1 · Reply
takingstock73
takingstock73 Sep. 24 at 4:39 PM
$ATRA let's go
0 · Reply
shoagh12
shoagh12 Sep. 24 at 3:16 PM
0 · Reply
JazzyJ03
JazzyJ03 Sep. 24 at 3:14 PM
0 · Reply
Smurfologist
Smurfologist Sep. 24 at 2:47 PM
$ATRA has beat the last 3 reporting quarters STRAIGHT; let's see if they will beat in the 3rd quarter.......LET'S GO, DAMN IT!!! 🙏🏾💪🏾🐃💣💥🚀
0 · Reply
Smurfologist
Smurfologist Sep. 24 at 2:43 PM
$ATRA is lookin' good rat now......CONGRATS TO THE LONGS and thanks for slappin' them SHORTS in dey mouf HARD!!! DO DAT $HIT, $ATRA!!! 🙏🏾💪🏾🐃💣💥🚀
0 · Reply
Smurfologist
Smurfologist Sep. 24 at 2:37 PM
$ATRA, YOU ARE A MONSTA!!!!! GIT IT, GURL!!!!! KAAAAAAAAAAAAAAABOOOOOOOOOOOOOOOM🙏🏾💪🏾🐃💣💥🚀
0 · Reply
Smurfologist
Smurfologist Sep. 24 at 1:51 PM
$ATRA, is $13.25 a reality or a fantasy?!? Make me a believer, $ATRA!!! 🙏🏾💪🏾🐃💣💥🚀
0 · Reply
Smurfologist
Smurfologist Sep. 23 at 5:16 PM
$ATRA has legs!!! Now, convince me and hit $13.00, damn it!!! 🙏🏾💪🏾🐃💣💥🚀
1 · Reply
takingstock73
takingstock73 Sep. 16 at 1:30 PM
$ATRA when do we start to see some anticipation trading approaching Jan decision ?
0 · Reply
Doozio
Doozio Sep. 6 at 4:40 PM
Roger needs to start rocking $ATRA $TIL how many STOKs are the BILI’s while da huckleberries go thru da $$$ for $EPRX during 🐒🍌🧠⏰♾️
0 · Reply
Smurfologist
Smurfologist Sep. 5 at 2:08 PM
$ATRA has FINALLY crossed over $13.00 on Freaky Friday......Let's see if it can hit $13.25; LET'S GO, DAMN IT 🙏🏾🐃💪🏾💣💥🚀
0 · Reply
takingstock73
takingstock73 Sep. 2 at 7:19 PM
0 · Reply
ChartScope
ChartScope Aug. 23 at 6:19 AM
$ATRA Atara Biotherapeutics is a cell therapy company facing clinical setbacks and significant funding needs
1 · Reply
Ulong
Ulong Aug. 20 at 8:36 AM
$ATRA 👇👇👇
1 · Reply
aitrades23
aitrades23 Aug. 20 at 2:50 AM
0 · Reply
Stockslingin
Stockslingin Aug. 20 at 2:46 AM
0 · Reply
AlertsAndNews
AlertsAndNews Aug. 20 at 2:44 AM
$ATRA Atara Biotherapeutics: James Huang (Director, 10%+) Buys 55,000 Shares at $12.19 Avg – Form 4 Director James Huang disclosed the purchase of 55,000 shares, totaling roughly $670K.
1 · Reply